$AMRX
Amneal Pharmaceuticals, Inc.

2019 Q4 Form 10-K Financial Statement

#000156459020008179 Filed on March 02, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4 2018 Q3
Revenue $397.3M $497.5M $476.5M
YoY Change -20.14% 87.05%
Cost Of Revenue $273.4M $302.9M $276.4M
YoY Change -9.74% 77.76% 130.86%
Gross Profit $110.2M $193.4M $200.1M
YoY Change -43.0% 27.73% 48.21%
Gross Profit Margin 27.74% 38.87% 42.0%
Selling, General & Admin $79.10M $77.50M $75.49M
YoY Change 2.06% 21.09% 175.09%
% of Gross Profit 71.76% 40.07% 37.72%
Research & Development $48.10M $56.60M $42.35M
YoY Change -15.02% 260.51% 2.48%
% of Gross Profit 43.63% 29.26% 21.16%
Depreciation & Amortization $54.30M $47.50M $17.36M
YoY Change 14.32% 97.92% 62.53%
% of Gross Profit 49.26% 24.56% 8.67%
Operating Expenses $127.1M $134.1M $117.8M
YoY Change -5.22% 71.36%
Operating Profit -$16.87M $59.31M $74.56M
YoY Change -128.44% -60.83% -5.33%
Interest Expense -$34.10M -$40.10M -$43.02M
YoY Change -14.96% -264.34% 123.84%
% of Operating Profit -67.61% -57.7%
Other Income/Expense, Net -$200.0K $2.100M -$51.98M
YoY Change -109.52% -800.0% -0.74%
Pretax Income -$57.10M -$14.80M $22.57M
YoY Change 285.81% -95.23% -14.44%
Income Tax $7.800M $5.700M $5.109M
% Of Pretax Income 22.63%
Net Earnings -$64.90M -$20.33M $6.888M
YoY Change 219.25%
Net Earnings / Revenue -16.33% -4.09% 1.45%
Basic Earnings Per Share -$0.23 -$0.07 $0.05
Diluted Earnings Per Share -$0.23 -$0.07 $0.05
COMMON SHARES
Basic Shares Outstanding 127.2M
Diluted Shares Outstanding 128.2M

Balance Sheet

Concept 2019 Q4 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $151.2M $213.4M $165.2M
YoY Change -29.15% 17.38% 4.76%
Cash & Equivalents $151.2M $213.4M $165.2M
Short-Term Investments
Other Short-Term Assets $71.80M $87.10M $40.20M
YoY Change -17.57% 63.11% -33.77%
Inventory $381.1M $457.2M $490.8M
Prepaid Expenses
Receivables $604.4M $481.5M $641.0M
Other Receivables $16.00M $16.98M $18.36M
Total Short-Term Assets $1.210B $1.287B $1.431B
YoY Change -5.94% 66.68% 126.04%
LONG-TERM ASSETS
Property, Plant & Equipment $478.0M $544.1M $567.5M
YoY Change -12.16% 11.79% 154.26%
Goodwill $419.5M $426.2M $410.6M
YoY Change -1.58% 1511.81%
Intangibles $1.383B $1.655B $1.733B
YoY Change -16.45% 3610.78%
Long-Term Investments
YoY Change
Other Assets $44.27M $67.59M $73.64M
YoY Change -34.5% 500.44% -2.33%
Total Long-Term Assets $2.456B $3.066B $3.151B
YoY Change -19.91% 437.95% 210.11%
TOTAL ASSETS
Total Short-Term Assets $1.210B $1.287B $1.431B
Total Long-Term Assets $2.456B $3.066B $3.151B
Total Assets $3.666B $4.353B $4.582B
YoY Change -15.78% 224.37% 177.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $103.0M $114.8M $124.5M
YoY Change -10.3% 64.04% 131.92%
Accrued Expenses $14.40M $399.6M $388.6M
YoY Change -96.4% 61.06% 55.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $78.10M
YoY Change
Long-Term Debt Due $21.48M $21.45M $121.7M
YoY Change 0.14% -75.95% 583.71%
Total Short-Term Liabilities $550.4M $553.9M $749.3M
YoY Change -0.62% 86.55% 114.69%
LONG-TERM LIABILITIES
Long-Term Debt $2.609B $2.631B $2.675B
YoY Change -0.82% 94.1% 248.37%
Other Long-Term Liabilities $39.58M $38.78M $44.77M
YoY Change 2.07% 397.63% -7.31%
Total Long-Term Liabilities $2.769B $2.903B $2.917B
YoY Change -4.61% 104.32% 257.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $550.4M $553.9M $749.3M
Total Long-Term Liabilities $2.769B $2.903B $2.917B
Total Liabilities $3.319B $3.456B $3.667B
YoY Change -3.97% 214.15%
SHAREHOLDERS EQUITY
Retained Earnings -$377.9M -$20.92M -$12.15M
YoY Change 1706.31% -94.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $232.0M $504.8M $501.1M
YoY Change
Total Liabilities & Shareholders Equity $3.666B $4.353B $4.582B
YoY Change -15.78% 224.37% 177.83%

Cashflow Statement

Concept 2019 Q4 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$64.90M -$20.33M $6.888M
YoY Change 219.25%
Depreciation, Depletion And Amortization $54.30M $47.50M $17.36M
YoY Change 14.32% 97.92% 62.53%
Cash From Operating Activities -$50.90M $259.6M $62.20M
YoY Change -119.61% -645.61%
INVESTING ACTIVITIES
Capital Expenditures -$4.700M -$20.00M -$37.50M
YoY Change -76.5% 669.23% 621.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $25.30M -$3.300M
YoY Change -100.0% -675.0% -137.5%
Cash From Investing Activities -$4.800M $5.300M -$40.80M
YoY Change -190.57% -1233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.300M -218.9M 82.60M
YoY Change -96.67% -1601.82%
NET CHANGE
Cash From Operating Activities -50.90M 259.6M 62.20M
Cash From Investing Activities -4.800M 5.300M -40.80M
Cash From Financing Activities -7.300M -218.9M 82.60M
Net Change In Cash -63.00M 46.00M 104.0M
YoY Change -236.96% -881.95%
FREE CASH FLOW
Cash From Operating Activities -$50.90M $259.6M $62.20M
Capital Expenditures -$4.700M -$20.00M -$37.50M
Free Cash Flow -$46.20M $279.6M $99.70M
YoY Change -116.52% 10653.85% -1708.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1662991000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1147214000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
938773000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
507476000
CY2019 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
126162000
CY2018 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
7815000
CY2017 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
0
CY2018 us-gaap Gross Profit
GrossProfit
716403000
CY2017 us-gaap Gross Profit
GrossProfit
526178000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109046000
CY2019 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-12442000
CY2017 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
29312000
CY2019 us-gaap Royalty Expense
RoyaltyExpense
14238000
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001723128
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2019 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.01 per share
CY2019 amrx Net Income Loss Attributable To Acquirer Prior To Business Combination
NetIncomeLossAttributableToAcquirerPriorToBusinessCombination
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y3M18D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y8M12D
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-38485
CY2019 dei Entity Registrant Name
EntityRegistrantName
Amneal Pharmaceuticals, Inc.
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0546926
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
400 Crossing Boulevard
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Bridgewater
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08807
CY2019 dei City Area Code
CityAreaCode
908
CY2019 dei Local Phone Number
LocalPhoneNumber
947-3120
CY2019 dei Trading Symbol
TradingSymbol
AMRX
CY2019 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
1201759491
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1626373000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1033654000
CY2019 us-gaap Gross Profit
GrossProfit
352997000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
289598000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
227846000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
188049000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194190000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
171420000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
46619000
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
39259000
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
16388000
CY2018 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
221818000
CY2017 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
9403000
CY2019 us-gaap Restructuring Charges
RestructuringCharges
34345000
CY2018 us-gaap Restructuring Charges
RestructuringCharges
56413000
CY2017 us-gaap Restructuring Charges
RestructuringCharges
0
CY2018 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
19711000
CY2018 us-gaap Royalty Expense
RoyaltyExpense
16261000
CY2017 us-gaap Royalty Expense
RoyaltyExpense
20518000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-248682000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-19673000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
245103000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-168205000
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-143571000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-71061000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1465000
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32753000
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1677000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-361917000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-19744000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
0
CY2018 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1176000
CY2017 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4962000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19701000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
29092000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19667000
CY2017 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-29232000
CY2019 amrx Gain From Reduction Of Tax Receivable Agreement Liability
GainFromReductionOfTaxReceivableAgreementLiability
192884000
CY2018 amrx Gain From Reduction Of Tax Receivable Agreement Liability
GainFromReductionOfTaxReceivableAgreementLiability
1665000
CY2017 amrx Gain From Reduction Of Tax Receivable Agreement Liability
GainFromReductionOfTaxReceivableAgreementLiability
0
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2532000
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
7258000
CY2018 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-2958000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1183000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28440000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-183049000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-73780000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-220242000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202722000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
171323000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
383331000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1419000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1998000
CY2019 us-gaap Profit Loss
ProfitLoss
-603573000
CY2018 us-gaap Profit Loss
ProfitLoss
-201303000
CY2017 us-gaap Profit Loss
ProfitLoss
169325000
CY2019 amrx Net Income Loss Attributable To Acquirer Prior To Business Combination
NetIncomeLossAttributableToAcquirerPriorToBusinessCombination
0
CY2018 amrx Net Income Loss Attributable To Acquirer Prior To Business Combination
NetIncomeLossAttributableToAcquirerPriorToBusinessCombination
-148806000
CY2017 amrx Net Income Loss Attributable To Acquirer Prior To Business Combination
NetIncomeLossAttributableToAcquirerPriorToBusinessCombination
167648000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-241656000
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32753000
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1677000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-361917000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-19744000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
0
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2018 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1176000
CY2017 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-361917000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20920000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.74
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
132106000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
127252000
CY2019 us-gaap Profit Loss
ProfitLoss
-603573000
CY2018 us-gaap Profit Loss
ProfitLoss
-201303000
CY2017 us-gaap Profit Loss
ProfitLoss
169325000
CY2018 amrx Net Income Loss Attributable To Acquirer Prior To Business Combination
NetIncomeLossAttributableToAcquirerPriorToBusinessCombination
-148806000
CY2017 amrx Net Income Loss Attributable To Acquirer Prior To Business Combination
NetIncomeLossAttributableToAcquirerPriorToBusinessCombination
167648000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-241656000
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-361917000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20920000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1233000
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3952000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2238000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-3413000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-803000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2180000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3952000
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1435000
CY2019 amrx Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination
0
CY2018 amrx Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination
1721000
CY2017 amrx Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination
-1435000
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
16373000
CY2018 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0
CY2017 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
10058000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-3256000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2417000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-353422000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23337000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151197000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8495000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213394000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1625000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5385000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
604390000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
481495000
CY2019Q4 us-gaap Inventory Net
InventoryNet
381067000
CY2018Q4 us-gaap Inventory Net
InventoryNet
457219000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70164000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
128321000
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1767000
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
830000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1210210000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1286644000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477997000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544146000
CY2019Q4 us-gaap Goodwill
Goodwill
419504000
CY2018Q4 us-gaap Goodwill
Goodwill
426226000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1382753000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1654969000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
373159000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44270000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67592000
CY2019Q4 us-gaap Assets
Assets
3665890000
CY2018Q4 us-gaap Assets
Assets
4352736000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
507483000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
514440000
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21479000
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
21449000
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5969000
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
17695000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
550406000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
553850000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2609046000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2630598000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1178000
CY2019Q4 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
0
CY2018Q4 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
192884000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39583000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38780000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2768696000
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2902523000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
606966000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
530438000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-377880000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20920000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7755000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
232010000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
504750000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
391613000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
346788000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
896363000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3665890000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4352736000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
896363000
CY2019 us-gaap Profit Loss
ProfitLoss
-603573000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1233000
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
16373000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21679000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1400000
CY2018 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
137403000
CY2019 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1113000
CY2019 amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
82000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
114778000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
-3413000
CY2018 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-2958000
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2532000
CY2017 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
45936000
CY2019 amrx Amortization Transition Agreement Payment
AmortizationTransitionAgreementPayment
36393000
CY2018 amrx Amortization Transition Agreement Payment
AmortizationTransitionAgreementPayment
10423000
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
7258000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
346788000
CY2017Q4 us-gaap Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest
LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest
-375582000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
896363000
CY2016Q4 us-gaap Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest
LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest
-175945000
CY2017Q4 us-gaap Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest
LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest
-375582000
CY2019 us-gaap Profit Loss
ProfitLoss
-603573000
CY2018 us-gaap Profit Loss
ProfitLoss
-201303000
CY2017 us-gaap Profit Loss
ProfitLoss
169325000
CY2019 amrx Gain Loss From Reduction Of Tax Receivable Agreement Liability
GainLossFromReductionOfTaxReceivableAgreementLiability
192884000
CY2018 amrx Gain Loss From Reduction Of Tax Receivable Agreement Liability
GainLossFromReductionOfTaxReceivableAgreementLiability
1665000
CY2017 amrx Gain Loss From Reduction Of Tax Receivable Agreement Liability
GainLossFromReductionOfTaxReceivableAgreementLiability
0
CY2019 amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
207235000
CY2017 amrx Amortization Transition Agreement Payment
AmortizationTransitionAgreementPayment
0
CY2019 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7342000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-18582000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
30823000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6478000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5859000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4585000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19667000
CY2017 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-29232000
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
172781000
CY2018 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
47074000
CY2017 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2019 amrx Noncash Restructuring Costs And Asset Impairment Charges
NoncashRestructuringCostsAndAssetImpairmentCharges
12459000
CY2018 amrx Noncash Restructuring Costs And Asset Impairment Charges
NoncashRestructuringCostsAndAssetImpairmentCharges
11295000
CY2017 amrx Noncash Restructuring Costs And Asset Impairment Charges
NoncashRestructuringCostsAndAssetImpairmentCharges
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
371716000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9439000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
742000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
21679000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
167597000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
82245000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
44539000
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
3771000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7309000
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1866000
CY2017 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9935000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
132726000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-89084000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35255000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20393000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42021000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31826000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-38870000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8775000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25305000
CY2018 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-10928000
CY2019 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
939000
CY2017 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
8208000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1705000
CY2017 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
5485000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10257000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
250230000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-53547000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18105000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
234187000
CY2019 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5228000
CY2018 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-14113000
CY2018 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
27742000
CY2017 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
40000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
13625000
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
324634000
CY2019 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47181000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83088000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94771000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50250000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000000
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19500000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2019 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0
CY2019 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
43017000
CY2018 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0
CY2018 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-75000000
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2017 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40376000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25344000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2019 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
34834000
CY2018 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0
CY2017 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
15717000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19580000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-396378000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98554000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2018 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
54955000
CY2017 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5026000
CY2019 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0
CY2018 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
1325383000
CY2017 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
250000000
CY2019 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
27000000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
617051000
CY2017 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
50000000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1400000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3797000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
926000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2019 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
CY2018 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
360000
CY2017 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-865000
CY2019 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0
CY2018 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
11775000
CY2017 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0
CY2019 amrx Payments For Acquisition Of Non Controlling Interests
PaymentsForAcquisitionOfNonControllingInterests
3543000
CY2018 amrx Payments For Acquisition Of Non Controlling Interests
PaymentsForAcquisitionOfNonControllingInterests
0
CY2017 amrx Payments For Acquisition Of Non Controlling Interests
PaymentsForAcquisitionOfNonControllingInterests
0
CY2019 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
13494000
CY2018 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
35543000
CY2017 amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
0
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
182998000
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
375265000
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
92042000
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45833000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
287675000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95015000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2249000
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-670000
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-242000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-65957000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
140857000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218779000
CY2018 amrx Tax Distribution To Non Controlling Interest
TaxDistributionToNonControllingInterest
13412000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77922000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37546000
CY2017 amrx Tax Distribution To Non Controlling Interest
TaxDistributionToNonControllingInterest
0
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152822000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218779000
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2018 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
CY2018Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
8562000
CY2017 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
14758000
CY2019 amrx Transaction Costs Paid By Parent
TransactionCostsPaidByParent
0
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2019 amrx Proceeds From Purchase Of Noncontrolling Interests
ProceedsFromPurchaseOfNoncontrollingInterests
0
CY2018 amrx Proceeds From Purchase Of Noncontrolling Interests
ProceedsFromPurchaseOfNoncontrollingInterests
3485000
CY2017 amrx Proceeds From Purchase Of Noncontrolling Interests
ProceedsFromPurchaseOfNoncontrollingInterests
0
CY2019 amrx Tax Distribution To Non Controlling Interest
TaxDistributionToNonControllingInterest
0
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77922000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151197000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213394000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74166000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1625000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5385000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3756000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152822000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218779000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77922000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
158568000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
131505000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
65086000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10255000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
34952000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-5780000
CY2019 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0
CY2018 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0
CY2017 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
1936000
CY2018 amrx Transaction Costs Paid By Parent
TransactionCostsPaidByParent
0
CY2017 amrx Transaction Costs Paid By Parent
TransactionCostsPaidByParent
8561000
CY2018Q2 amrx Shares Repurchased Percentage
SharesRepurchasedPercentage
0.15
CY2019Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
64000000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, billbacks, allowances for accounts receivable, accrued liabilities, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</p>
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5000000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8020000
CY2019 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period balances have been reclassified to conform to the current period presentation.  These reclassifications did not have a material impact on the consolidated statements of operations, consolidated balance sheets, consolidated statements of cash flows<span style="font-family:Calibri;font-size:11pt;"> </span>or notes to the consolidated financial statements.</p>
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85000000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
86000000
CY2019Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
64000000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1033654000
CY2018 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1839083000
CY2017 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1809441000
CY2018 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-163915000
CY2017 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-340223000
CY2018 amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
-30270000
CY2017 amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
-109920000
CY2019 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2018 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2017 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1626373000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1662991000
CY2019 us-gaap Restructuring Charges
RestructuringCharges
34345000
CY2018 us-gaap Restructuring Charges
RestructuringCharges
56413000
CY2017 us-gaap Restructuring Charges
RestructuringCharges
0
CY2019 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
16388000
CY2018 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
35319000
CY2017 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9403000
CY2019 amrx Profit Sharing Expense
ProfitSharingExpense
0
CY2018 amrx Profit Sharing Expense
ProfitSharingExpense
158757000
CY2017 amrx Profit Sharing Expense
ProfitSharingExpense
0
CY2019 amrx Transaction Related Bonus Expense
TransactionRelatedBonusExpense
0
CY2018 amrx Transaction Related Bonus Expense
TransactionRelatedBonusExpense
27742000
CY2017 amrx Transaction Related Bonus Expense
TransactionRelatedBonusExpense
0
CY2019 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
16388000
CY2018 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
221818000
CY2017 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
9403000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1256000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
171323000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
365546000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2967000
CY2018Q2 amrx Deferred Tax Asset Basis Difference In Investment Portion Attributable To Acquirer Prior To Business Combination
DeferredTaxAssetBasisDifferenceInInvestmentPortionAttributableToAcquirerPriorToBusinessCombination
306000000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-2760000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2299000
CY2018Q2 amrx Deferred Tax Asset Operating Loss Carryforward Portion Attributable To Acquirer Prior To Business Combination
DeferredTaxAssetOperatingLossCarryforwardPortionAttributableToAcquirerPriorToBusinessCombination
55000000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
470000000
CY2019 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2019Q4 amrx Reversal Of Accrued Tax Receivable Agreement Liability
ReversalOfAccruedTaxReceivableAgreementLiability
193000000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
383000000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.74
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.012
CY2019 amrx Income Tax Returns Examination Period
IncomeTaxReturnsExaminationPeriod
P3Y
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-220242000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202722000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
14375000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5721000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1256000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11615000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
6170000
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-6472000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
742000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
371716000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9439000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
742000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
383331000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1419000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1998000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.151
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.011
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0
CY2019 amrx Effective Income Tax Rate Reconciliation Loss No Benefit Recognized Percent
EffectiveIncomeTaxRateReconciliationLossNoBenefitRecognizedPercent
-0.258
CY2018 amrx Effective Income Tax Rate Reconciliation Loss No Benefit Recognized Percent
EffectiveIncomeTaxRateReconciliationLossNoBenefitRecognizedPercent
-0.123
CY2017 amrx Valuation Allowance Deferred Tax Asset Decrease Divestitures
ValuationAllowanceDeferredTaxAssetDecreaseDivestitures
23900000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
470193000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41235000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
304000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41617000
CY2017 amrx Effective Income Tax Rate Reconciliation Loss No Benefit Recognized Percent
EffectiveIncomeTaxRateReconciliationLossNoBenefitRecognizedPercent
0.106
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.055
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.063
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.065
CY2019 amrx Effective Income Tax Rate Reconciliation Tax Receivable Agreement Revaluation
EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementRevaluation
0.184
CY2018 amrx Effective Income Tax Rate Reconciliation Tax Receivable Agreement Revaluation
EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementRevaluation
0.002
CY2017 amrx Effective Income Tax Rate Reconciliation Tax Receivable Agreement Revaluation
EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementRevaluation
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.682
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.012
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.008
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.029
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.740
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.012
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41235000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41617000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42231000
CY2019 amrx Valuation Allowance Deferred Tax Asset Increase Decrease Current Year Net Operating Losses And Temporary Differences
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseCurrentYearNetOperatingLossesAndTemporaryDifferences
424692000
CY2018 amrx Valuation Allowance Deferred Tax Asset Increase Decrease Current Year Net Operating Losses And Temporary Differences
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseCurrentYearNetOperatingLossesAndTemporaryDifferences
-382000
CY2017 amrx Valuation Allowance Deferred Tax Asset Increase Decrease Current Year Net Operating Losses And Temporary Differences
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseCurrentYearNetOperatingLossesAndTemporaryDifferences
23286000
CY2019 amrx Increase Decrease Recorded Against Additional Paid In Capital
IncreaseDecreaseRecordedAgainstAdditionalPaidInCapital
4266000
CY2018 amrx Increase Decrease Recorded Against Additional Paid In Capital
IncreaseDecreaseRecordedAgainstAdditionalPaidInCapital
0
CY2018 amrx Valuation Allowance Deferred Tax Asset Decrease Divestitures
ValuationAllowanceDeferredTaxAssetDecreaseDivestitures
0
CY2019Q4 amrx Deferred Tax Assets Partnership Interest
DeferredTaxAssetsPartnershipInterest
226049000
CY2018Q4 amrx Deferred Tax Assets Partnership Interest
DeferredTaxAssetsPartnershipInterest
240044000
CY2019Q4 amrx Deferred Tax Assets Projected Imputed Interest On Tax Receivable Agreement
DeferredTaxAssetsProjectedImputedInterestOnTaxReceivableAgreement
25278000
CY2018Q4 amrx Deferred Tax Assets Projected Imputed Interest On Tax Receivable Agreement
DeferredTaxAssetsProjectedImputedInterestOnTaxReceivableAgreement
9838000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
119088000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
107942000
CY2019Q4 amrx Deferred Tax Assets Tax Credit Carryforwards Interest
DeferredTaxAssetsTaxCreditCarryforwardsInterest
44978000
CY2018Q4 amrx Deferred Tax Assets Tax Credit Carryforwards Interest
DeferredTaxAssetsTaxCreditCarryforwardsInterest
33789000
CY2018Q4 amrx Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
900000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
4298000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
31677000
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1553000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
22819000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
16030000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
470193000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
414394000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
470193000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41235000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
373159000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1178000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1178000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
371981000
CY2019Q4 us-gaap Deferred Tax Asset Intra Entity Transfer Asset Other Than Inventory
DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory
60000000
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6000000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7000000
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
6000000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
132106000
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
7000000
CY2019 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
400000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
127252000
CY2018 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
200000
CY2019Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
1000000
CY2018Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
600000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7206000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
83000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
182000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
732000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2346000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
0
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
5208000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
0
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
530000
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
381000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6176000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7206000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018 amrx Income Tax Returns Examination Period
IncomeTaxReturnsExaminationPeriod
P3Y
CY2019Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
79000000
CY2019 amrx Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Global Intangible Low Taxed Income
TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseGlobalIntangibleLowTaxedIncome
30000000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-361917000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20920000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.74
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1470706000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1349588000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2201000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2340000
CY2019Q4 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
829807000
CY2018Q4 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
829596000
CY2019Q4 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
34308000
CY2018Q4 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
36157000
CY2019Q4 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
866316000
CY2018Q4 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
868093000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
604390000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
481495000
CY2019 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2018 amrx Concentration Risk Number Of Largest Customers
ConcentrationRiskNumberOfLargestCustomers
3
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
172159000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
181654000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
58188000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
54152000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
150720000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
221413000
CY2019Q4 us-gaap Inventory Net
InventoryNet
381067000
CY2018Q4 us-gaap Inventory Net
InventoryNet
457219000
CY2019 amrx Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
26000000
CY2018 amrx Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
18000000
CY2017 amrx Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
17000000
CY2019 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2000000
CY2019 amrx Operating Short Term And Variable Lease Cost
OperatingShortTermAndVariableLeaseCost
22544000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3468000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4641000
CY2019 amrx Finance Lease Cost
FinanceLeaseCost
8109000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
69872000
CY2019 us-gaap Lease Cost
LeaseCost
30653000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
73025000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
61284000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
62517000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
4272000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
20122000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2256000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4874000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P22Y
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.071
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18970000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
5474000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17052000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
5474000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13426000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
5474000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11244000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5474000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9864000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5474000
CY2018Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
199857000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
95217000
CY2019Q4 amrx Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
7143000
CY2019Q4 amrx Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
5474000
CY2019Q4 amrx Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
12846000
CY2019Q4 amrx Finance Lease Liability Payments Due After Year Six
FinanceLeaseLiabilityPaymentsDueAfterYearSix
95792000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
90545000
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
128636000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17520000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
66119000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
73025000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
62517000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
25885000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
5474000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
12071000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5474000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
11105000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5474000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
10329000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5474000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
10043000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5474000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
28128000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
107196000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
97561000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
134566000
CY2018Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
0
CY2018Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
97561000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
39349000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1123000
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2142000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3858000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
6094000
CY2019Q4 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
4016000
CY2018Q4 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
4924000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
13740000
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
29625000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3255000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
15996000
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16979000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
28176000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
32164000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70164000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
128321000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
754042000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
753582000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
276045000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
209436000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477997000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544146000
CY2019 us-gaap Depreciation
Depreciation
63283000
CY2018 us-gaap Depreciation
Depreciation
64417000
CY2017 us-gaap Depreciation
Depreciation
41962000
CY2018Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25000000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
131043000
CY2018Q4 us-gaap Goodwill
Goodwill
426226000
CY2017Q4 us-gaap Goodwill
Goodwill
26444000
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1255000
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
401488000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5175000
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-292000
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1706000
CY2019Q4 us-gaap Goodwill
Goodwill
419504000
CY2018Q4 us-gaap Goodwill
Goodwill
426226000
CY2019Q3 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
CY2019Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1200535000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
199857000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000678000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1294636000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
91597000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1203039000
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
382075000
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
382075000
CY2018Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
451930000
CY2018Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
451930000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1582610000
CY2018Q4 amrx Accrued Sales Returns Allowance Current
AccruedSalesReturnsAllowanceCurrent
154503000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1382753000
CY2018Q4 amrx Redeemable Non Controlling Interest Remained Outstanding Amount
RedeemableNonControllingInterestRemainedOutstandingAmount
0
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
126522000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36008000
CY2018 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-696000
CY2019Q4 amrx Finite Lived Intangible Assets Amortization Expense After Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix
310591000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000678000
CY2018 amrx Changes In Reallocation Of Ownership Interests
ChangesInReallocationOfOwnershipInterests
7173000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
139380000
CY2019Q4 amrx Accrued Sales Returns Allowance Current
AccruedSalesReturnsAllowanceCurrent
150361000
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1746566000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
91597000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1654969000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
143952000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72986000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3974000
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
382000000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
144382000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
148760000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
103021000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
114846000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77066000
CY2019Q4 amrx Accrued Sales Rebates Current
AccruedSalesRebatesCurrent
114960000
CY2018Q4 amrx Accrued Sales Rebates Current
AccruedSalesRebatesCurrent
74202000
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
28969000
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
23639000
CY2019Q4 amrx Sales Rebate Reimbursement Current
SalesRebateReimbursementCurrent
7000000
CY2018Q4 amrx Sales Rebate Reimbursement Current
SalesRebateReimbursementCurrent
15000000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
12312000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4555000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8729000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1159000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35897000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36193000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
507483000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
514440000
CY2019 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
7035000
CY2019Q3 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
43000000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2659500000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2686500000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
28975000
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
34453000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
2630525000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
2652047000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21479000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21449000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2609046000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2630598000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20000000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5000000
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3000000
CY2017Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
3000000
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2019Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
16000000
CY2015Q1 amrx Number Of Generic Medication Included In Antitrust Division Of Division Of Justice
NumberOfGenericMedicationIncludedInAntitrustDivisionOfDivisionOfJustice
4
CY2018 amrx Transaction Related Bonus Expense
TransactionRelatedBonusExpense
28000000
CY2018 amrx Profit Share And Transaction Related Bonus Expense
ProfitShareAndTransactionRelatedBonusExpense
187000000
CY2018 amrx Profit Sharing Expense
ProfitSharingExpense
159000000
CY2018 amrx Transaction Related Bonus Expense
TransactionRelatedBonusExpense
28000000
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1461000
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
183000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
49000000
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
0
CY2018Q4 amrx Dueto Related Parties Tax Distribution
DuetoRelatedPartiesTaxDistribution
13000000
CY2019Q4 amrx Dueto Related Parties Tax Distribution
DuetoRelatedPartiesTaxDistribution
0
CY2018Q4 amrx Noncontrolling Interest Number Of Subsidiaries Acquired
NoncontrollingInterestNumberOfSubsidiariesAcquired
1
CY2018Q4 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
3000000
CY2018Q2 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
12000000
CY2019Q4 amrx Redeemable Non Controlling Interest Remained Outstanding Amount
RedeemableNonControllingInterestRemainedOutstandingAmount
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2019 amrx Changes In Reallocation Of Ownership Interests
ChangesInReallocationOfOwnershipInterests
-809000
CY2018Q2 amrx Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConverted
3000000.0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2018 amrx Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConverted
3002669
CY2018 amrx Share Based Compensation Arrangement By Share Based Payment Award Options Converted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConvertedWeightedAverageExercisePrice
18.90
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3555808
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.64
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
351668
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.80
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
392228
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
23.02
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5814581
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.73
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2600000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4559820
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.29
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
210806
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.64
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3986469
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.07
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6177126
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.87
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8000000.0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2072310
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
18.59
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
600000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3600000
CY2019Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2019 amrx Allocated Share Based Compensation Incremental Expense
AllocatedShareBasedCompensationIncrementalExpense
900000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
46000000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21679000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8840000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2018 us-gaap Gross Profit
GrossProfit
716403000
CY2019 us-gaap Royalty Expense
RoyaltyExpense
14238000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
227846000
CY2019 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-12442000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44270000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-248682000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
7000000
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
7000000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3000000
CY2019 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
0
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019 amrx Number Of Product Families
NumberOfProductFamilies
200
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1626373000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1147214000
CY2019 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
126162000
CY2019 us-gaap Gross Profit
GrossProfit
352997000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
289598000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
188049000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
46619000
CY2019 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
16388000
CY2019 us-gaap Restructuring Charges
RestructuringCharges
34345000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1662991000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
938773000
CY2018 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
7815000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194190000
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
39259000
CY2018 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
221818000
CY2018 us-gaap Restructuring Charges
RestructuringCharges
56413000
CY2018 us-gaap Royalty Expense
RoyaltyExpense
16261000
CY2018 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
19711000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-19673000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1033654000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
507476000
CY2017 us-gaap Gross Profit
GrossProfit
526178000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109046000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
171420000
CY2017 us-gaap Royalty Expense
RoyaltyExpense
20518000
CY2017 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
29312000
CY2017 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
9403000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
245103000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
497528000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67592000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
446120000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
404642000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378283000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
397328000
CY2019Q1 us-gaap Gross Profit
GrossProfit
83080000
CY2019Q2 us-gaap Gross Profit
GrossProfit
105249000
CY2019Q3 us-gaap Gross Profit
GrossProfit
54434000
CY2019Q4 us-gaap Gross Profit
GrossProfit
110234000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-124752000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-50526000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-363392000
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-64903000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47881000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16902000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-265006000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32128000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.03
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.03
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
275189000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413787000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
476487000
CY2018Q1 us-gaap Gross Profit
GrossProfit
144595000
CY2018Q2 us-gaap Gross Profit
GrossProfit
178295000
CY2018Q3 us-gaap Gross Profit
GrossProfit
200105000
CY2018Q4 us-gaap Gross Profit
GrossProfit
193408000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
51652000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-250090000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
17465000
CY2018Q4 us-gaap Profit Loss
ProfitLoss
-20330000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19104000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6952000
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8768000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07

Files In Submission

Name View Source Status
0001564590-20-008179-index-headers.html Edgar Link pending
0001564590-20-008179-index.html Edgar Link pending
0001564590-20-008179.txt Edgar Link pending
0001564590-20-008179-xbrl.zip Edgar Link pending
amrx-10k_20191231.htm Edgar Link pending
amrx-10k_20191231_htm.xml Edgar Link completed
amrx-20191231.xsd Edgar Link pending
amrx-20191231_cal.xml Edgar Link unprocessable
amrx-20191231_def.xml Edgar Link unprocessable
amrx-20191231_lab.xml Edgar Link unprocessable
amrx-20191231_pre.xml Edgar Link unprocessable
amrx-ex1012_8.htm Edgar Link pending
amrx-ex211_11.htm Edgar Link pending
amrx-ex231_9.htm Edgar Link pending
amrx-ex311_16.htm Edgar Link pending
amrx-ex312_15.htm Edgar Link pending
amrx-ex313_6.htm Edgar Link pending
amrx-ex321_17.htm Edgar Link pending
amrx-ex322_18.htm Edgar Link pending
amrx-ex323_10.htm Edgar Link pending
amrx-ex42_12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gervt05l4p5u000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending